Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | myriocin | CTRPv2 | pan-cancer | AAC | 0.027 | 0.7 |
mRNA | palmostatin B | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | Dasatinib | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | AZD6482 | CTRPv2 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | 0.0099 | 0.7 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0093 | 0.8 |
mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | -0.01 | 0.8 |
mRNA | BRD-K07442505 | CTRPv2 | pan-cancer | AAC | -0.011 | 0.8 |